Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
about
Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons.Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β.Casein kinase 1α: biological mechanisms and theranostic potential.Establishing sheep as an experimental species to validate ultrasound-mediated blood-brain barrier opening for potential therapeutic interventions.A Study of Amyloid-β and Phosphotau in Plaques and Neurons in the Hippocampus of Alzheimer's Disease Patients.Potential Utility of Retinal Imaging for Alzheimer’s Disease: A Review.The distinct structural preferences of tau protein repeat domainsDetection of Alzheimer's Disease
P2860
Q49962856-F4BDED80-76AA-408D-919C-8A39782E8980Q52568535-549A58CF-1A2D-49C5-92CD-A582EB126669Q54940982-AF3990DE-62AF-4C1B-9DD8-45C8ECFCD590Q55148397-EAF752E1-DDE5-4285-A6C8-12FFF35386F9Q55421819-CDED42FC-7CC7-46E6-B6E3-46407D3E6250Q55480248-E2EDEF33-6B3F-4F2F-A747-ABEFBA41D1EEQ57840232-981F9628-657B-4F6D-BD68-D65F1C3AC077Q58706105-B4D0D178-BB5E-4BCA-B5C7-20D955F0001B
P2860
Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
@en
Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
@nl
type
label
Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
@en
Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
@nl
prefLabel
Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
@en
Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
@nl
P2860
P50
P1476
Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies
@en
P2093
Chuanzhou Li
Jürgen Götz
P2860
P2888
P356
10.1038/NRNEUROL.2017.162
P407
P577
2017-12-15T00:00:00Z